J&J to provide US government with additional 100 million Covid vaccine doses
Raises projected supply of one-dose shot to 200 million
Though difficult to believe, it has been one year since the World Health Organization declared the Covid-19 outbreak a pandemic.
Since then, there has been plenty of progress in the quest to combat the virus. In the past couple of weeks alone, key vaccine-activity developments have surfaced, including the announcement that Johnson & Johnson would be teaming up with Merck to help manufacture the J&J vaccine.
J&J chairman and CEO Alex Gorsky recently visited the White House, where President Biden announced that the US would be purchasing an additional 100 million doses of the company's Covid-19 vaccine. Last August, J&J signed an agreement with the US government to deliver 100 million doses of its vaccine—a commitment, the company says, it is on track to meet.
Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration
May 8th 2025The track-and-trace systems provider expands its life sciences portfolio by integrating the high-speed, adaptable ETF-300 precision labeler through a partnership that brings Industry 4.0-ready capabilities, advanced printing tech, and enhanced data security to pharmaceutical packaging.
